Ermeza 0.03 MG/ML Oral Solution
- RxCUI
- 2626056
- RxNorm name
- Ermeza 0.03 MG/ML Oral Solution
- Display name
- Ermeza 0.03 MG/ML Oral Solution
- Full name
- Ermeza 0.03 MG/ML Oral Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8ceeadb4-18be-46c7-9204-68b4edfbb96b | Ermeza 0.03 MG/ML Oral Solution | SY | 6 | These highlights do not include all the information needed to use ERMEZA™ safely and effectively. See full prescribing information for ERMEZA™. ERMEZA™ (levothyroxine sodium) oral solution Initial U.S. Approval: 2000 | 20220415 |
| 8ceeadb4-18be-46c7-9204-68b4edfbb96b | Ermeza 150 MCG per 5 ML Oral Solution | SY | 6 | These highlights do not include all the information needed to use ERMEZA™ safely and effectively. See full prescribing information for ERMEZA™. ERMEZA™ (levothyroxine sodium) oral solution Initial U.S. Approval: 2000 | 20220415 |
| 8ceeadb4-18be-46c7-9204-68b4edfbb96b | levothyroxine sodium 0.03 MG/ML Oral Solution [Ermeza] | SBD | 6 | These highlights do not include all the information needed to use ERMEZA™ safely and effectively. See full prescribing information for ERMEZA™. ERMEZA™ (levothyroxine sodium) oral solution Initial U.S. Approval: 2000 | 20220415 |
| 8ceeadb4-18be-46c7-9204-68b4edfbb96b | Ermeza 150 MCG in 5 mL Oral Solution | PSN | 6 | These highlights do not include all the information needed to use ERMEZA™ safely and effectively. See full prescribing information for ERMEZA™. ERMEZA™ (levothyroxine sodium) oral solution Initial U.S. Approval: 2000 | 20220415 |
| 8ceeadb4-18be-46c7-9204-68b4edfbb96b | Ermeza 30 MCG per ML Oral Solution | SY | 6 | These highlights do not include all the information needed to use ERMEZA™ safely and effectively. See full prescribing information for ERMEZA™. ERMEZA™ (levothyroxine sodium) oral solution Initial U.S. Approval: 2000 | 20220415 |